Pediatr Blood Cancer
Antineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, HeterocyclicCytarabine
Dr. Andrew E. Place, MD, PhD
NPI1083898373
- Publications
- 40
- Clinical trials
- 7
- Hospital affiliations
- 1
- Industry payments
- $19,595
- Medical groups
- 2
- Practice address
- 300 Longwood Avenue, Boston, MA 02115
- Practice phone
- Call (617) 735-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Place's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Andrew E. Place is a pediatric hematology and oncology physician in Boston, Massachusetts
Dr. Place practices at Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital.
Dr. Place's NPI, 1083898373, was assigned on December 21, 2007. Dr. Place holds Massachusetts license 238782.
NPI and contact details
- NPI
- 1083898373NPI Registry (opens in a new tab)
- NPI enumeration date
- December 21, 2007
- NPI status
- Active
- Practice phone
- (617) 735-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Andrew E. Place practices at Boston Children's Hospital in Boston, Massachusetts
Dr. Place's primary practice is Boston Children's Hospital, at 300 Longwood Avenue, Boston, MA 02115 in Suffolk County. The practice phone is (617) 735-6000.
- Boston Children's Hospital300 Longwood Avenue, Boston, MA 02115 · Suffolk CountyPhone(617) 735-6000
Source: Dmand AI Affiliation Data
Dr. Andrew E. Place is affiliated with 2 sites of care and 2 medical groups
Dr. Place's primary practice is Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital. The medical group on file is Boston Children's Hospital. Dmand AI also links Dr. Place to 1 more dialysis center and 1 medical group, each named with a free account.
Boston Children's Hospital1 dialysis centerName with a free account1 medical groupName with a free account
See all 4 affiliations for Dr. PlaceSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Andrew E. Place's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Place practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Boston Children's Hospital | Available with a free account |
| +1 more site and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Place practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across The Children's Hospital and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Andrew E. Place is one of 159 pediatric hematologys and oncology physicians in Massachusetts
Pediatric hematology-oncology is Dr. Place's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Place is licensed in Massachusetts.
Specialties and state licenses
- Pediatric hematology and oncology, MassachusettsPrimary
Pediatric hematologys and oncology physicians near Dr. Place
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
159pediatric hematologys and oncology physicians in Massachusetts141pediatric hematologys and oncology physicians in Boston92pediatric hematologys and oncology physicians at Boston Children's Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Andrew E. Place's patients have a median age of 12
Across all payers, Dmand AI patient panel data puts Dr. Place's median patient age at 12, with 42% women.
Dr. Place's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 12
Patient panel by sex, all payers
- Women42%
- Men57%
Source: Dmand AI Patient Panel Data
Dr. Andrew E. Place has 40 publications on record
Dmand AI links 40 papers to Dr. Place, published from 2011 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols and Asparaginase. Dr. Place has published most often in Pediatr Blood Cancer. Dr. Place's most frequent co-authors are Lewis B. Silverman, MD, Lynda M. Vrooman, MD and Todd M. Cooper, DO.
Papers40
Years published2011 to 2025
Dr. Place's papers by year, 2015 to 2025
Topics Dr. Place writes about most
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antineoplastic Combined Chemotherapy Protocols
- Asparaginase
- Antineoplastic Agents
- Bridged Bicyclo Compounds, Heterocyclic
- Drug Resistance, Neoplasm
- Leukemia, Myeloid, Acute
- Lymphoma
Dr. Place's most frequent co-authors
- Lewis B. Silverman, MD13 shared papers
- Lynda M. Vrooman, MD11 shared papers
- Todd M. Cooper, DO9 shared papers
Recent publications by Dr. Place
Pediatr Blood Cancer
Antineoplastic Combined Chemotherapy ProtocolsAsparaginaseBridged Bicyclo Compounds, Heterocyclic
Antineoplastic Combined Chemotherapy ProtocolsLiposomesPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Antineoplastic Combined Chemotherapy ProtocolsAsparaginasePrecursor Cell Lymphoblastic Leukemia-Lymphoma
See who Dr. Place researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Place works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Andrew E. Place has worked on 7 clinical trials
Dmand AI links Dr. Place to 7 clinical trials, 3 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Disease Attributes. Dana-Farber Cancer Institute sponsors the most, 3.
Clinical trials with Dr. Place by phase
- 3Phase 1: 3 trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Place's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
- Disease Attributes
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Neoplasm, Residual
Investigators on the most trials with Dr. Place
Recent clinical trials with Dr. Place
Matched Targeted Therapy (MTT) Recommendation for Patients With Recurrent, Refractory, or High Risk Leukemias and Myelodysplastic Syndrome (opens in a new tab)
Active, not recruiting
Disease AttributesPathological Conditions, Signs and SymptomsLeukemia Profiling
Leukemia, Myeloid, AcuteLeukemia, MyeloidCytarabineDecitabineFludarabine
A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (opens in a new tab)
TerminatedPhase 1/2
PonatinibChemotherapy Agents
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients (opens in a new tab)
Active, not recruitingPhase 2
Neoplasm, ResidualBurkitt LymphomaCTL019
Leukemia, Myeloid, AcuteLeukemia, MyeloidDasatinibCytarabineFludarabine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Andrew E. Place received $19,595 in industry payments from 2016 to 2024
CMS Open Payments shows 25 general payments to Dr. Place from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 85% of the total. Jazz Pharmaceuticals Inc. paid the most, $6,775.
General payments to Dr. Place by program year, 2016 to 2024
General payments to Dr. Place by kind, 2016 to 2024
$19.6Kin total
- Consulting fees$16,59885%
- Travel and lodging$1,93110%
- Food and beverage$1,0665%
Companies that paid Dr. Place the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Andrew E. Place's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Andrew E. Place
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Andrew E. Place's NPI number?
Dr. Andrew E. Place's NPI number is 1083898373. It was assigned on December 21, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Andrew E. Place?
Dr. Andrew E. Place is a pediatric hematology and oncology physician in Boston, Massachusetts. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Andrew E. Place practice?
Dr. Place practices at 300 Longwood Avenue, Boston, MA 02115. Dr. Place's primary practice is Boston Children's Hospital in Boston, Massachusetts, part of The Children's Hospital. Dmand AI also links Dr. Place to 1 dialysis center and 1 medical group.
What is Dr. Andrew E. Place's office phone number?
The practice phone on file for Dr. Place is (617) 735-6000.
What is Dr. Andrew E. Place's medical license number?
Dr. Place holds Massachusetts license 238782.
Which hospitals is Dr. Andrew E. Place affiliated with?
Dr. Place practices at Boston Children's Hospital in Boston, Massachusetts.
What medical group is Dr. Andrew E. Place part of?
Dr. Place is linked to Boston Children's Hospital. Dmand AI links Dr. Place to 1 more medical group.
Has Dr. Andrew E. Place received payments from drug or device companies?
CMS Open Payments shows $19,595 in general payments to Dr. Place from 7 companies from 2016 to 2024. The largest total came from Jazz Pharmaceuticals Inc.
How long has Dr. Andrew E. Place been practicing?
Dr. Place's NPI was assigned in 2007.
Does Dr. Andrew E. Place do research?
Dmand AI links 40 publications to Dr. Place, published from 2011 to 2025. Dr. Place has worked on 7 clinical trials.
Who does Dr. Andrew E. Place publish with?
Dr. Place's most frequent co-authors are Lewis B. Silverman, MD (13 shared papers), Lynda M. Vrooman, MD (11 shared papers) and Todd M. Cooper, DO (9 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card